Lead product commercialization and launch consultant for Fortune 200 client:
● Project 1 (6 months). Developed commercial/GTM plan for combination rapid viral test. Managed global (50 country) pre-commercialization and launch activities. Performed market research. Built market/financial model.
● Project 2 (3 months): Developed marketing and training materials for antibody test. Managed global (30 countries) launch execution and coordinated global and regional team activities. Multiple teams.
● Project 3 (6 months): Developed global (35 country) commercial/GTM plan for POC respiratory rapid diagnostic technology. Managed pre-commercialization and launch activities – multiple teams. Developed comprehensive marketing plan and directed multiple design/marcom vendors. Developed KOL program.
● Project 4 (3 months): Developed and executed global advisory board program to inform POC HIV diagnostic RTD, positioning and early test-to-treat programs. Created plan to change SOC algorithms wit

Bold Health Ltd. (Digital therapeutics for GI): Strategy and business development/execution (2019 – 2020)
•Lilu, Inc (Femtech, lactation technologies post-partum): Developed/executed commercial strategy (2019 – 2020)
•Kalia Health, Inc. (Femtech rapid LF test for preeclampsia): Developed commercial strategy (2019 – 2020)

Led product development and commercial market entry of a next generation sequence (NGS) data and clinical decision support platform to generate precision therapeutic care plans in oncology for stage 3/4 cancer patients.
•Sales & business development: Managed US sales/marketing teams to identify and develop commercial accounts.
•Product development: Led upstream VOC/beta-site activities to iterate and achieve product-market fit in the US.
•Product management: Developed and executed marketing programs to drive awareness, trialing and adoption.

Developed a digital health platform for health diagnostics/lab tests. Successfully launched web/mobile/app portal with e-commerce, LIMS, and supply-chain integration.
•Implemented B2C commercial model: Value-added diagnostic test platform for core and preventive health.
•Led business development: Identified and partnered with national labs to purchase bulk lab-testing capacity.
•Directed web portal and software development. Directed omnichannel sales and marketing activities.

Managed product development and successfully launched an ultrasound-based multi-module ophthalmology diagnostic platform with a portable console. Ran clinical programs in partnership with Sheba medical Center.
•Product development and commercialization: Led the development and launch activities of the 4Sight® System
•R&D management: Directed the development of a visual field device with the Sheba Medical Center in Israel.

Seno Medical Inc (opto-acoustic diagnostic technology for breast cancer diagnosis): Developed strategic marketing plan; Formulated value proposition and messaging; Developed pricing model. (2014 – 2015)
•Xenex, Inc. (UV-based disinfectant): Developed rollout plan for global commercialization. Executed pilot. (2014)
•Juice Central: Conceived, designed, and franchised juice/health-store-themed retail outlet. Set up 2 stores. (2014)

Led the market development and global commercialization of two polymer-based implantable technologies: drug eluting embolic microspheres (interventional radiology) & surface-modified stents (interventional cardiology).
•Led the global launch of Embozene™ TANDEM™ Microspheres:
● Directed and managed precommercial and upstream marketing activities across all continents.
● Developed and conducted education programs via a KOL-driven center of excellence program.
● Coordinated global and regional clinical trials to develop body of evidence for market adoption and access.
•Set up global commercial footprint via distributor partnerships at regional and country level.
● Designed and implemented comprehensive plan to train, coach and mentor distributor sales reps globally.
● Created sales tools and marketing collateral, customized for regional clinical and administrative audiences.

•Acelity India: Led market entry commercialization, JV partnership, business set-up, and wound care product launches.

Director, Corporate Development (US) 2005 – 2008
•Acelity Japan: Led market entry commercialization planning/strategy, business set-up, & wound-care product launch.
•Business development & execution: Managed all deal stages for various technology and M&A transactions.
•Divisional strategy development and execution: Led and implemented divisional strategic plans and BD functions.

Conceptualized, developed, and launched medical products business